Emerging Infections 10

by W. Michael Scheld (Editor), James M. Hughes (Editor), Richard J. Whitley (Editor)

Overview

Essential resource for the fight against emerging infectious diseases

Incidences such as the 2014 Ebola epidemic in West Africa and the 2015 appearance of Zika in Brazil provide dramatic evidence of the continued ability of microbes to emerge, spread, adapt, and threaten global health. The challenge facing infectious disease specialists and public health professionals is to improve and find new diagnostic, therapeutic, and prevention strategies.

The editors of the 10th installment of the Emerging Infections series have compiled the perspectives of leading infectious disease experts into 22 chapters that provide important updates on a broad range of emerging and reemerging bacterial, viral, parasitic, and fungal infectious diseases in the United States and globally. In addition to focusing on MERS, Ebola virus disease, chikungunya, and Zika virus disease, Emerging Infections 10 explores the global threat of antimicrobial resistance in reviews on carbapenem-resistant Enterobacteriaceae, multiply-resistant gonococcal infections, non-typhoidal Salmonella infections, and artemisinin-resistant Plasmodium falciparum malaria. Topics include both recently- and long-recognized diseases that pose challenges for the clinical, laboratory, research, public health, and animal health communities.

Emerging Infections 10 presents new and emerging strategies to prevent, control, and eradicate infectious diseases and guides readers to the primary literature where they can explore individual topics in greater depth. This book is a valuable reference for professionals in microbiology, epidemiology, public health, and clinical and veterinary medicine.

Product Details

ISBN-13:	9781683673217
Publisher:	Wiley
Publication date:	06/01/2016
Series:	ASM Books
Sold by:	JOHN WILEY & SONS
Format:	eBook
Pages:	464
File size:	16 MB
Note:	This product may take a few minutes to download.

About the Author

W. Michael Scheld, MD, is the Bayer-Gerald Mandell Professor of Infectious Diseases, Professor of Medicine, Clinical Professor of Neurosurgery, and Director of the Center for Global Health at the University of Virginia School of Medicine. Dr. Scheld’s research includes the molecular pathogenesis and pathophysiology of bacterial infections, anti-inflammatory mechanisms of adenosine receptor subtype agonists and antagonists, antimicrobial resistance, sepsis and septic shock, anthrax, and international health issues including HIV/AIDS in Africa.

James M. Hughes, MD, is Professor of Medicine and Public Health with joint appointments in the School of Medicine (Infectious Diseases) and the Rollins School of Public Health (Global Health) at Emory University and Co-Director of the Emory Antibiotic Resistance Center. Dr. Hughes’ research includes emerging and reemerging infectious diseases; antimicrobial resistance; healthcare-associated infections; vectorborne and zoonotic diseases; foodborne and waterborne diseases; vaccine-preventable diseases; rapid detection of and response to infectious diseases and bioterrorism; and strategies for strengthening public health capacity at the local, national, and global levels.

Table of Contents

Contributors ix

Foreword xv

Preface xvii

Acknowledgments xix

1 West Africa 2013: Re-examining Ebola 1
Daniel G. Bausch and Amanda Rojek

2 Preparing for Serious Communicable Diseases in the United States: What the Ebola Virus Epidemic Has Taught Us 39
Jay B. Varkey and Bruce S. Ribner

3 Ebola Virus Disease: Therapeutic and Potential Preventative Opportunities 53
Robert Fisher and Luciana Borio

4 Middle East Respiratory Syndrome (MERS) 73
Sonja A. Rasmussen, Amelia K. Watson, and David L. Swerdlow

5 The Emergence of Enterovirus D-68 105
Kevin Messacar, Mark J. Abzug, and Samuel R. Dominguez

6 The Role of Punctuated Evolution in the Pathogenicity of Influenza Viruses 121
Jonathan A. McCullers

7 Measles in the United States since the Millennium: Perils and Progress in the Postelimination Era 131
Anne Schuchat, Amy Parker Fiebelkorn, and William Bellini

8 Chikungunya Virus: Current Perspectives on a Reemerging Virus 143
Clayton R. Morrison, Kenneth S. Plante, and Mark T. Heise

9 Zika Virus Disease 163
Werner Slenczka

10 West Nile Virus Infection 175
James J. Sejvar

11 Mobilization of Carbapenemase-Mediated Resistance in Enterobacteriaceae 201
Amy Mathers

12 Antimicrobial Resistance Expressed by Neisseria gonorrhoeae: A Major Global Public Health Problem in the 21st Century 213
Magnus Unemo, Carlos del Rio, and William M. Shafer

13 Bordetella holmesii: Still Emerging and Elusive 20 Years On 239
Laure F. Pittet and Klara M. Posfay-Barbe

14 Cronobacter spp. 255
Brian P. Blackwood and Catherine J. Hunter

15 Clostridium difficile Infection 265
Jae Hyun Shin, Esteban Chaves-Olarte, and Cirle A. Warren

16 Emerging Tick-Borne Bacterial Pathogens 295
Tahar Kernif, Hamza Leulmi, Didier Raoult, and Philippe Parola

17 Bordetella pertussis 311
Delma J. Nieves and Ulrich Heininger

18 Invasive Infections with Nontyphoidal Salmonella in Sub-Saharan Africa 341
Barbara E. Mahon and Patricia I. Fields

19 Fungal Infections Associated with Contaminated Steroid Injections 359
Carol A. Kauffman and Anurag N. Malani

20 Emerging Fungal Infections in the Pacific Northwest: The Unrecognized Burden and Geographic Range of Cryptococcus gattii and Coccidioides immitis 375
Shawn R. Lockhart, Orion Z. McCotter, and Tom M. Chiller

21 The Emerging Amphibian Fungal Disease, Chytridiomycosis: A Key Example of the Global Phenomenon of Wildlife Emerging Infectious Diseases 385
Jonathan E. Kolby and Peter Daszak

22 Artemisinin-Resistant Plasmodium falciparum Malaria 409
Rick M. Fairhurst and Arjen M. Dondorp

Index 431

Editorial Reviews

Description

The 10th volume of this series, which originated in 1998, remains highly pertinent and informative as emerging and re-emerging infectious diseases become ever more important. Written by 49 well-qualified authors (including over a dozen from outside the U.S.) from major academic institutions as well as the CDC, FDA, NIH, and WHO, the 22 chapters examine emerging pathogens MERS, Enterovirus D68, Chikungunya, Zika, carbapenem-resistant Enterobacteriaceae (CRE), antibiotic-resistant gonorrhea, etc. Three chapters are dedicated to Ebola due to its recent impact and general interest.

Purpose

The three well-known editors seek to update readers on a wide-ranging list of prominent emerging viral, bacterial, and fungal pathogens as well as a few less well-known or more esoteric pathogens such as B. holmesii, Cronobacter spp., tick-borne bacterial pathogens, and amphibian fungal diseases. In addition, several chapters deal with more mechanistic concerns such as punctuated evolution in the pathogenicity of influenza, fungal contamination of steroid injections, and challenges in preventing the re-emergence of measles.

Audience

Students, teachers, clinicians, laboratorians, and investigators in the disciplines of microbiology, infectious diseases, and public health will find value in the concise, well-written, and adequately referenced chapters.

Features

The foreword and preface do a nice job of setting the scene. The first three chapters on Ebola are organized into West African experience, lessons from Ebola in preparing for serious communicable diseases in the United States, and Ebola therapeutics. Although each chapter is excellent on its own, there is substantial redundancy when read together. To better hold the reader's attention, the authors of almost all of the chapters (exceptions are non-typhoidal salmonella and Zika) offer appropriate graphics, charts, and tables. The chapters on MERS, measles, Enterovirus D68, and C. difficile are concise yet comprehensive reviews. The scope of the chapter on CRE concentrates on epidemiology and laboratory detection but does not address other clinical issues.

Assessment

Global forces such as population growth, climate change, world travel, and trade will continue to influence the emergence and transmission of infectious diseases. This volume nicely summarizes information on a variety of pathogens and serves as a great reminder of the importance of preparedness and public health on a national and global scale.

Weighted Numerical Score: 90 - 4 Stars!

-DOODY'S REVIEW SERVICE (NO INDIVIDUAL REVIEWER NOTED)

From the Publisher

Reviewer: Mark E. Rupp, MD (University of Nebraska Medical Center )
Description: The 10th volume of this series, which originated in 1998, remains highly pertinent and informative as emerging and re-emerging infectious diseases become ever more important. Written by 49 well-qualified authors (including over a dozen from outside the U.S.) from major academic institutions as well as the CDC, FDA, NIH, and WHO, the 22 chapters examine emerging pathogens MERS, Enterovirus D68, Chikungunya, Zika, carbapenem-resistant Enterobacteriaceae (CRE), antibiotic-resistant gonorrhea, etc. Three chapters are dedicated to Ebola due to its recent impact and general interest.
Purpose: The three well-known editors seek to update readers on a wide-ranging list of prominent emerging viral, bacterial, and fungal pathogens as well as a few less well-known or more esoteric pathogens such as B. holmesii, Cronobacter spp., tick-borne bacterial pathogens, and amphibian fungal diseases. In addition, several chapters deal with more mechanistic concerns such as punctuated evolution in the pathogenicity of influenza, fungal contamination of steroid injections, and challenges in preventing the re-emergence of measles.
Audience: Students, teachers, clinicians, laboratorians, and investigators in the disciplines of microbiology, infectious diseases, and public health will find value in the concise, well-written, and adequately referenced chapters.
Features: The foreword and preface do a nice job of setting the scene. The first three chapters on Ebola are organized into West African experience, lessons from Ebola in preparing for serious communicable diseases in the United States, and Ebola therapeutics. Although each chapter is excellent on its own, there is substantial redundancy when read together. To better hold the reader's attention, the authors of almost all of the chapters (exceptions are non-typhoidal salmonella and Zika) offer appropriate graphics, charts, and tables. The chapters on MERS, measles, Enterovirus D68, and C. difficile are concise yet comprehensive reviews. The scope of the chapter on CRE concentrates on epidemiology and laboratory detection, but does not address other clinical issues.
Assessment: Global forces such as population growth, climate change, world travel, and trade will continue to influence the emergence and transmission of infectious diseases. This volume nicely summarizes information on a variety of pathogens and serves as a great reminder of the importance of preparedness and public health on a national and global scale.

Doody's Review Service